GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:45PM BST
| Previous close | 1,530.60 |
| Open | 1,529.80 |
| Bid | 1,527.60 x 0 |
| Ask | 1,527.20 x 0 |
| Day's range | 1,518.60 - 1,544.20 |
| 52-week range | 1,283.20 - 1,609.00 |
| Volume | |
| Avg. volume | 6,884,318 |
| Market cap | 62.564B |
| Beta (5Y monthly) | 0.30 |
| PE ratio (TTM) | 12.03 |
| EPS (TTM) | 1.27 |
| Earnings date | 01 Nov 2023 |
| Forward dividend & yield | 0.56 (3.63%) |
| Ex-dividend date | 17 Aug 2023 |
| 1y target est | N/A |
Fool.co.ukWas selling our GSK shares a big mistake?
GSK shares have had a good 12 months, easily beating the FTSE 100 index with an 18% gain. So was selling our stock in 2021/22 the wrong move? The post Was selling our GSK shares a big mistake? appeared first on The Motley Fool UK.
Fool.co.ukThree red hot LSE shares I’d consider buying before the next stock market rally
I'm looking for shares that will lead the next stock market rally and recent performance suggests these three should all do well. The post Three red hot LSE shares I’d consider buying before the next stock market rally appeared first on The Motley Fool UK.
ZacksIncyte (INCY) Down on FDA Nod for Another Myelofibrosis Drug
Incyte (INCY) declines on potential competition for lead drug Jakafi from Ojjaara for the treatment of intermediate or high-risk myelofibrosis.
© 2023 Yahoo. All rights reserved.
